Seok-Young Kim

10PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyMolecular medicineTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 20, 2026
A Phase II Study of Stereotactic Ablative Radiotherapy plus Atezolizumab plus Tiragolumab in Treatment-Naïve Patients with Advanced Non-Small Cell Lung Cancer.

|Dec 05, 2024
Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab.

Dong Kwon Kim, Chun-Bong Synn, Wongeun Lee

|Jun 25, 2024
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.

Sun M Lim, Seong-San Kang, Dong K Kim

|Oct 21, 2022
Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC.

Seung Yeon Oh, You Won Lee, Eun Ji Lee

|Dec 16, 2021
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor.

Chun-Bong Synn, Dong Kwon Kim, Jae Hwan Kim

|May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.

Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim

Pageof 2

Frequent Collaborators

8 joint publications

Min Hee Hong

6 joint publications

Kyoung-Ho Pyo

6 joint publications

Sun Min Lim

5 joint publications

Sun Min Lim